What is the prognosis for acute angle-closure glaucoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prognosis of Acute Angle-Closure Glaucoma

The prognosis of acute angle-closure glaucoma (AACG) is generally favorable when treated promptly with laser iridotomy, with most patients achieving visual acuity ≥6/12 (meeting UK driving standards), though approximately 10-15% may develop severe visual impairment or blindness from glaucomatous damage, particularly when presentation is delayed or baseline visual field defects are present. 1, 2

Visual Outcomes

The majority of patients maintain good functional vision after AACG:

  • 73% achieve visual acuity ≥6/12 at long-term follow-up, meeting driving standards 2
  • Only 15% develop severe visual impairment (WHO definition), with approximately 6-10% attributable to glaucoma alone 2, 3
  • 14.7% may become blind in the affected eye, with 9.6% due to glaucoma specifically 3

These outcomes reflect modern treatment approaches including timely laser iridotomy and appropriate IOP management.

Key Prognostic Factors

Factors Associated with Worse Outcomes

Delayed presentation is the single most critical modifiable risk factor that worsens prognosis 4, 2:

  • Increases risk of requiring additional medical treatment (OR 2.83) 2
  • The time needed to terminate the acute attack correlates with worse long-term outcomes 4
  • Trabecular meshwork damage and peripheral anterior synechiae (PAS) formation occur during prolonged angle closure 1

Higher mean follow-up IOP independently predicts glaucomatous progression (OR 1.14 per mm Hg increase) 3

Worse baseline visual field defects at presentation predict progression (OR 1.07 per 1 dB worsening) 3

Older age is associated with worse visual outcomes (OR 1.26 per year) 2

Protective Factors

Early cataract extraction (within 3 months) is protective against progression (OR 0.43), partly mediated through improved IOP control 3. Patients undergoing phacoemulsification show:

  • Lower risk of blindness (OR 0.18) 2
  • Lower risk of elevated IOP (OR 0.10) 2
  • Reduced need for additional medical treatment (OR 0.34) 2

Important Clinical Caveat

The initial IOP height during the acute attack does NOT predict long-term prognosis 4. This is a critical point—extremely high pressures during the attack are less important than how quickly treatment is initiated and how well IOP is controlled afterward.

Structural and Functional Damage

Even with successful IOP normalization after early lens extraction, approximately 49% of patients may develop residual visual field defects 5. These defects correlate with:

  • Thinner Bruch's membrane opening-minimum rim width (BMO-MRW)
  • Reduced peripapillary retinal nerve fiber layer (RNFL) thickness
  • Reduced lamina cribrosa thickness and shallower depth
  • Wider parapapillary atrophy 5

Timely treatment can prevent or retard damage to the optic nerve, trabecular meshwork, iris, lens, and cornea 1.

Fellow Eye Risk

The fellow eye carries substantial risk and requires urgent prophylactic treatment 1:

  • Approximately 50% of untreated fellow eyes develop AACG within 5 years 1
  • Attacks can occur within days of the initial presentation
  • Prophylactic laser peripheral iridotomy (LPI) should be performed as soon as possible
  • Even with prophylactic LPI, 53% may still develop primary angle closure glaucoma after 6 years of follow-up 1

Long-term Management Requirements

After the acute episode is resolved with iridotomy:

  • 82.7% of patients undergo cataract extraction during follow-up 3
  • 31.4% require glaucoma surgery for IOP control 3
  • Visual acuity, IOP, and medication burden typically improve over time 3
  • Mean visual field and RNFL thickness may remain stable if IOP is well-controlled 3

Treatment Algorithm Impact on Prognosis

The prognosis directly depends on the treatment pathway:

  1. Immediate medical IOP reduction → prevents ongoing damage during acute phase 1
  2. Laser iridotomy within hours to days → eliminates pupillary block and prevents recurrence 1
  3. Early cataract extraction (within 3 months) → significantly improves long-term outcomes 3, 2
  4. Aggressive IOP control to target pressures → prevents progression in those with established damage 3

The prognosis fundamentally shifts from poor to good when this treatment sequence is executed promptly, emphasizing that AACG is a true ophthalmic emergency requiring same-day intervention.

References

4
Research

Long-term outcome of primary acute angle-closure glaucoma.

The British journal of ophthalmology, 1985

Related Questions

In a 64-year-old hyperopic woman presenting with sudden severe unilateral ocular pain, headache, nausea, vomiting, blurred vision, halos around lights, and a mid‑dilated sluggish pupil, what is the most likely diagnosis?
Can angle‑closure glaucoma exist without being an acute crisis, or is acute angle‑closure glaucoma always an emergency?
Can acute angle‑closure glaucoma occur without ocular symptoms, and is that relatively common?
As an urgent care provider (AGPCNP), does a 52‑year‑old male with a few‑day history of headache, right‑eye blurry vision, red eye and moderate corneal edema have an ocular emergency such as acute closed‑angle glaucoma?
What are the prodromal symptoms of acute angle-closure glaucoma before a full crisis?
What is the recommended misoprostol regimen for medication termination of pregnancy at 7 weeks gestation?
What is the appropriate treatment for a widespread atopic dermatitis rash?
With a noon blood pressure of 146/92 mmHg, pulse 80 bpm, and mild headache while taking telmisartan 80 mg (MICARDIS ANLO) combined with amlodipine 5 mg daily, what management steps should be taken?
Is duloxetine (serotonin‑norepinephrine reuptake inhibitor) pharmacologically related to statins (HMG‑CoA reductase inhibitors)?
What could be causing my left groin pain that has persisted for one month, with sharp episodes lasting minutes, not relieved by acetaminophen (Tylenol) but improved by heat?
What is the recommended surveillance and management strategy for an aortic mural thrombus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.